{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:53:55Z","timestamp":1759366435436,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.revmed.2015.06.007","type":"journal-article","created":{"date-parts":[[2015,7,8]],"date-time":"2015-07-08T13:35:45Z","timestamp":1436362545000},"page":"127-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Troubles neuropsychiatriques inexpliqu\u00e9s\u00a0: penser aux enc\u00e9phalites dysimmunitaires. \u00c0 propos d\u2019une observation d\u2019enc\u00e9phalite \u00e0 anticorps anti-leucine rich glioma inactivated\u00a01 (LGI-1)"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0622-3371","authenticated-orcid":false,"given":"E.","family":"Le Dault","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Lagarde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Guedj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Dufournet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Rey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Kaphan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Tanguy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bregigeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Sagui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Brosset","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2015.06.007_bib0110","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1474-4422(11)70096-5","article-title":"Autoantibodies associated with diseases of the CNS: new developments and future challenges","volume":"10","author":"Vincent","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.revmed.2015.06.007_bib0115","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.24200","article-title":"Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms","volume":"76","author":"Irani","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2015.06.007_bib0120","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neurol.2012.05.014","article-title":"Autoimmune encephalitis, clinical, radiological and immunological data","volume":"169","author":"Aupy","year":"2013","journal-title":"Rev Neurol"},{"key":"10.1016\/j.revmed.2015.06.007_bib0125","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.neurol.2014.07.007","article-title":"Therapeutic approaches in antibody-associated central nervous system pathologies","volume":"170","author":"Honnorat","year":"2014","journal-title":"Rev Neurol"},{"key":"10.1016\/j.revmed.2015.06.007_bib0130","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","article-title":"Investigation of LGI1\u00a0as the antigen in limbic encephalitis previously attributed to potassium channels: a case series","volume":"9","author":"Lai","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.revmed.2015.06.007_bib0135","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1\u00a0potassium channel-complex proteins leucine-rich, glioma inactivated 1\u00a0protein and contactin-associated protein-2\u00a0in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.revmed.2015.06.007_bib0140","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1093\/brain\/awt212","article-title":"Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype","volume":"136","author":"Irani","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.revmed.2015.06.007_bib0145","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/awh077","article-title":"Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis","volume":"127","author":"Vincent","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.revmed.2015.06.007_bib0150","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ana.22307","article-title":"Faciobrachial dystonic seizures precede Lgi1\u00a0antibody limbic encephalitis","volume":"69","author":"Irani","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2015.06.007_bib0155","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(14)60684-X","article-title":"Pathognomonic seizures in limbic encephalitis associated with anti-LGI1\u00a0antibodies","volume":"383","author":"Sen","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2015.06.007_bib0160","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jneuroim.2013.10.005","article-title":"VGKC-complex\/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy","volume":"265","author":"Shin","year":"2013","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.revmed.2015.06.007_bib0165","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1212\/01.WNL.0000122648.19196.02","article-title":"Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody","volume":"62","author":"Thieben","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2015.06.007_bib0170","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ana.21430","article-title":"Rapidly progressive dementia","volume":"64","author":"Geschwind","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.revmed.2015.06.007_bib0175","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1176\/jnp.23.4.jnp425","article-title":"Psychiatric manifestations of voltage-gated potassium-channel complex autoimmunity","volume":"23","author":"Somers","year":"2011","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.revmed.2015.06.007_bib0180","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1212\/WNL.0b013e31825f0522","article-title":"Immunotherapy-responsive chorea as the presenting feature of LGI1-antibody encephalitis","volume":"79","author":"Tofaris","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2015.06.007_bib0185","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1212\/01.wnl.0000312275.04260.a0","article-title":"Clinical spectrum of voltage-gated potassium channel autoimmunity","volume":"70","author":"Tan","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2015.06.007_bib0190","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1528-1167.2009.02287.x","article-title":"Adult-onset drug-refractory seizure disorder associated with anti-voltage-gated potassium-channel antibody","volume":"51","author":"Barajas","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.revmed.2015.06.007_bib0195","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.yebeh.2010.01.017","article-title":"Improvement of non-paraneoplastic voltage-gated potassium channel antibody-associated limbic encephalitis without immunosuppressive therapy","volume":"17","author":"Gast","year":"2010","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.revmed.2015.06.007_bib0200","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1600-0404.2005.00406.x","article-title":"FDG-PET and MRI in potassium channel antibody-associated non-paraneoplastic limbic encephalitis: correlation with clinical course and neuropsychology","volume":"111","author":"Fauser","year":"2005","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.revmed.2015.06.007_bib0205","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1471-2377-14-136","article-title":"Anti-leucine rich glioma inactivated 1\u00a0protein and anti-N-methyl-D-aspartate receptor encephalitis show distinct patterns of brain glucose metabolism in 18F-fluoro-2-deoxy-d-glucose positron emission tomography","volume":"14","author":"Wegner","year":"2014","journal-title":"BMC Neurol"},{"key":"10.1016\/j.revmed.2015.06.007_bib0105","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jns.2014.05.048","article-title":"Natural course of LGI1\u00a0encephalitis: 3\u20135\u00a0years of follow-up without immunotherapy","volume":"343","author":"Szots","year":"2014","journal-title":"J Neurol Sci"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866315005524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866315005524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:35:26Z","timestamp":1759336526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866315005524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0248866315005524"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2015.06.007","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Troubles neuropsychiatriques inexpliqu\u00e9s\u00a0: penser aux enc\u00e9phalites dysimmunitaires. \u00c0 propos d\u2019une observation d\u2019enc\u00e9phalite \u00e0 anticorps anti-leucine rich glioma inactivated\u00a01 (LGI-1)","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2015.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Soci\u00e9t\u00e9 nationale fran\u00e7aise de m\u00e9decine interne (SNFMI). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}